Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens.

The intestinal 'organoid' (iHO) system, wherein 3-D structures representative of the epithelial lining of the human gut can be produced from human induced pluripotent stem cells (hiPSCs) and maintained in culture, provides an exciting opportunity to facilitate the modeling of the epithelial response to enteric infections. In vivo, intestinal epithelial cells (IECs) play a key role in regulating intestinal homeostasis and may directly inhibit pathogens, although the mechanisms by which this occurs are not fully elucidated. The cytokine interleukin-22 (IL-22) has been shown to play a role in the maintenance and defense of the gut epithelial barrier, including inducing a release of antimicrobial peptides and chemokines in response to infection. We describe the differentiation of healthy control hiPSCs into iHOs via the addition of specific cytokine combinations to their culture medium before embedding them into a basement membrane matrix-based prointestinal culture system. Once embedded, the iHOs are grown in media supplemented with Noggin, R-spondin-1, epidermal growth factor (EGF), CHIR99021, prostaglandin E2, and Y-27632 dihydrochloride monohydrate. Weekly passages by manual disruption of the iHO ultrastructure lead to the formation of budded iHOs, with some exhibiting a crypt/villus structure. All iHOs demonstrate a differentiated epithelium consisting of goblet cells, enteroendocrine cells, Paneth cells, and polarized enterocytes, which can be confirmed via immunostaining for specific markers of each cell subset, transmission electron microscopy (TEM), and quantitative PCR (qPCR). To model infection, Salmonella enterica serovar Typhimurium SL1344 are microinjected into the lumen of the iHOs and incubated for 90 min at 37 °C, and a modified gentamicin protection assay is performed to identify the levels of intracellular bacterial invasion. Some iHOs are also pretreated with recombinant human IL-22 (rhIL-22) prior to infection to establish whether this cytokine is protective against Salmonella infection.

[1]  Anneliese O. Speak,et al.  Interleukin-22 promotes phagolysosomal fusion to induce protection against Salmonella enterica Typhimurium in human epithelial cells , 2018, Proceedings of the National Academy of Sciences.

[2]  Hans Clevers,et al.  Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids , 2018, Cell.

[3]  H. Clevers,et al.  Modeling Cryptosporidium infection in human small intestinal and lung organoids , 2018, Nature Microbiology.

[4]  D. Ward,et al.  Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli , 2017, PloS one.

[5]  D. Graham,et al.  Replication of human noroviruses in stem cell–derived human enteroids , 2016, Science.

[6]  G. Dougan,et al.  Derivation of Intestinal Organoids from Human Induced Pluripotent Stem Cells for Use as an Infection System. , 2016, Methods in molecular biology.

[7]  P. Garcez,et al.  Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.

[8]  R. Durbin,et al.  A high-content platform to characterise human induced pluripotent stem cell lines , 2016, Methods.

[9]  Tetsuya Nakamura,et al.  Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes , 2016, Journal of Gastroenterology.

[10]  T. Lawley,et al.  Pathogen Resistance Mediated by IL-22 Signaling at the Epithelial-Microbiota Interface. , 2015, Journal of molecular biology.

[11]  D. Graham,et al.  Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology , 2015, Journal of Virology.

[12]  Shinichiro Ogawa,et al.  Directed differentiation of cholangiocytes from human pluripotent stem cells , 2015, Nature Biotechnology.

[13]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[14]  Gail H Deutsch,et al.  In vitro generation of human pluripotent stem cell derived lung organoids , 2015, eLife.

[15]  Takanori Kanai,et al.  Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids , 2015, Nature Medicine.

[16]  M. Spector,et al.  Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.

[17]  H. Mollenkopf,et al.  A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro , 2014, Gut.

[18]  E. Cuppen,et al.  Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures , 2014, Cell.

[19]  Sarah S. Wilson,et al.  A Small Intestinal Organoid Model of Non-invasive Enteric Pathogen-Epithelial Cell Interactions , 2014, Mucosal Immunology.

[20]  W. Ouyang,et al.  Therapeutic opportunities of the IL-22–IL-22R1 system , 2013, Nature Reviews Drug Discovery.

[21]  Hans Clevers,et al.  Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis , 2013, The EMBO journal.

[22]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[23]  Hans Clevers,et al.  Lgr5(+) liver stem cells, hepatic organoids and regenerative medicine. , 2013, Regenerative medicine.

[24]  Tamas L. Horvath,et al.  Modeling human cortical development in vitro using induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[25]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[26]  Hans Clevers,et al.  Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. , 2010, Cell stem cell.

[27]  S. Pestka,et al.  Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.